A Potential Daidzein Derivative Enhances Cytotoxicity of Epirubicin on Human Colon Adenocarcinoma Caco-2 Cells-Reference-Cited by-同舟云学术

A Potential Daidzein Derivative Enhances Cytotoxicity of Epirubicin on Human Colon Adenocarcinoma Caco-2 Cells

Published:2012-12-21 Issue:1 Volume:14 Page:158-176
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Lo Yu-Li

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/14/1/158/pdf

Reference48 articles.

1. Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro;Guo;Int. J. Gynecol. Cancer,2004

2. Cancer statistics, 2012;Siegel;CA Cancer J. Clin,2012

3. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling;Liu;Mol. Cancer,2010

4. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies;Wu;Curr. Mol. Pharmacol,2008

5. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin;Lo;Eur. J. Pharm. Sci,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daidzein nanosuspension combined with 5-fluorouracil induces apoptosis and alleviate inflammation in Caco-2 colorectal adenocarcinoma cells;Food Bioscience;2024-10

2. Equol exerts anti-tumor effects on choriocarcinoma cells by promoting TRIM21-mediated ubiquitination of ANXA2;Biology Direct;2024-09-06

3. Reactive oxygen species in colorectal cancer adjuvant therapies;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

4. Changes in isoflavone profile, antioxidant activity, and phenolic contents in Taiwanese and Canadian soybeans during tempeh processing;LWT;2023-08

5. Therapeutic Potential of Genistein and its Derivatives as a Target for Anticancer Agents;ChemistrySelect;2023-06